glp 1 from china The Evolution of GLP-1 Drugs in China GLP-1 Receptor Agonist Market
Description
Four patients had intraprocedural hypoxia (0.3%), two experienced aspiration (0.1%) and three (0.2%) had other adverse events such as bronchospasm and cholangitis
For some individuals, GLP-1 medications may be used strategically as part of a broader plan
doi:10.1007/s40262-018-0668-z 20
10.3389/fimmu.2019.01050 Summary Keywords T2DM, incretin effect, DPP-4 enzyme, DPP-4 inhibitors, (GLP)-1, insulin Citation Saini K, Sharma S and Khan Y (2023) DPP-4 inhibitors for treating T2DM - hype or hope
